Transgelin (TAGLN) (N-Term) Peptid
Kurzübersicht für Transgelin (TAGLN) (N-Term) Peptid (ABIN8114264)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- TAGLN Peptide - N-terminal region
-
Sequenz
- NKGPSYGMSR EVQSKIEKKY DEELEERLVE WIVVQCGPDV GRPDRGRLGF
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- TAGLN Antibody (ARP89876_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Transgelin (TAGLN)
-
Hintergrund
-
Background Information: This gene encodes a smooth muscle cell-specific cytoskeletal protein. The encoded protein is structurally similar to calponin, an actin-binding protein. In mouse models of atherosclerosis the gene product may be involved in plaque cell and atherosclerotic lesion formation during atherogenesis.
Alternative Symbols: Sm22, Sm22a, Ws310
-
Molekulargewicht
- 23 kDa
-
Gen-ID
- 21345
-
NCBI Accession
- NP_035656
-
UniProt
- P37804
Target
-